-
Intensification and novel risk classifications for high-risk PCa
November 8, 2024Plenary Session 2 “Addressing unmet needs: Approaches to prostate cancer challenges in high-risk and metastatic disease” kickstarted today with...
01 -
Stepping into their shoes: EU-ProPER studies partners of PCa patients
November 8, 2024What is the extent of the physical and psychological burdens that prostate cancer (PCa) imposes on the partners of...
-
Pathology: Is AI progressing in clinical application?
November 7, 2024In the European Society of Uropathology Symposium (ESUP) on Day 1 of EMUC24, expert speakers delivered updates on the...
-
Current evidence in PCa screening
November 7, 2024The inaugural session of the EAU Section of Urological Imaging programme, Plenary Session 1 “Prostate cancer screening” provided the...
-
EMUC24 preview: Pathology and imaging advancements, soft skills, and global health inequalities
September 26, 2024The upcoming 16th European Multidisciplinary Congress on Urological Cancers (Lisbon, Portugal from 7-10 November) is a key learning platform...
-
A new collaboration with the Kidney Cancer Association
September 3, 2024This year, the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24) will feature two plenary sessions designed by the...
-
Cross-disciplines and AI in focus at EMUC24: An advance look at what awaits you at the congress
July 3, 2024The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific...
-
RCC: Molecular imaging techniques? Delayed nephrectomy?
November 6, 2023Individualised approaches to kidney cancer were deliberated in Plenary Session 12 on the afternoon of day three at EMUC23....
-
mCRPC: Insights on Lu-PSMA, PARP inhibitors, and new targeted approaches
November 5, 2023The second half of Plenary Session 13 “New standards and novel approaches in advanced prostate cancer” was spearheaded by...
-
M1a disease, systemic triplet therapy, and de-escalation strategies in HSPC
November 5, 2023The last day of EMUC23 began with Plenary Session 13: New standards and novel approaches in advanced prostate cancer,...
News
EMUC25 > News
